Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices

por Ardura, Monica, Hartley, David, Dandoy, Christopher, Lehmann, Leslie, Jaglowski, Samantha, Auletta, Jeffery J.
Publicado 2020

Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience

por Schaefer, Andrew, Huang, Ying, Kittai, Adam, Maakaron, Joseph E, Saygin, Caner, Brammer, Jonathan, Penza, Sam, Saad, Ayman, Jaglowski, Samantha M, William, Basem M
Publicado 2021

Cutaneous graft-versus-host disease within chronic photodamaged skin: A case series demonstrating role for topical 5-fluorouracil

por Gray, Ashley N., Avila, Christina, Chung, Catherine G., Seminario-Vidal, Lucia, Mims, Alice, Dulmage, Brittany, Larkin, Karilyn, Choe, Hannah, Jaglowski, Samantha, Vasu, Sumithira, Kaffenberger, Benjamin H.
Publicado 2023

miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib.

por Guinn, Daphne, Ruppert, Amy S., Maddocks, Kami, Jaglowski, Samantha, Gordon, Amber, Lin, Thomas S., Larson, Richard, Marcucci, Guido, Hertlein, Erin, Woyach, Jennifer, Johnson, Amy J., Byrd, John C.
Publicado 2014

Bamlanivimab Monoclonal Antibody Treatment in Patients with Graft Versus Host Disease (GVHD) Diagnosed with COVID-19 Infection

por Faisal, Muhammad Salman, Saad, Ayman, Mims, Alice, Vasu, Sumithira, Wall, Sarah A., Larkin, Karilyn, Choe, Hannah, Brammer, Jonathan E., Penza, Sam, Jaglowski, Samantha, De Lima, Marcos
Publicado 2022

A single center’s experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation

por Haverkos, Bradley M., Huang, Ying, Elder, Patrick, O’Donnell, Lynn, Scholl, Diane, Whittaker, Becky, Vasu, Sumi, Penza, Sam, Andritsos, Leslie A., Devine, Steven M., Jaglowski, Samantha M.
Publicado 2017

The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma

por Jaglowski, Samantha M., Ruppert, Amy S., Hofmeister, Craig C., Elder, Patrick, Blum, William, Klisovic, Rebecca, Vasu, Sumithira, Penza, Sam, Efebera, Yvonne A, Benson, Don M., Devine, Steven M., Andritsos, Leslie A
Publicado 2014

The regulation of tumor‐suppressive microRNA, miR‐126, in chronic lymphocytic leukemia

por Guinn, Daphne, Lehman, Amy, Fabian, Catherine, Yu, Lianbo, Maddocks, Kami, Andritsos, Leslie A., Jones, Jeffrey A., Flynn, Joseph M., Jaglowski, Samantha M., Woyach, Jennifer A., Byrd, John C., Johnson, Amy J.
Publicado 2017

Dinaciclib is a Novel Cyclin Dependent Kinase Inhibitor with Significant Clinical Activity in Relapsed and Refractory Chronic Lymphocytic Leukemia

por Flynn, Joseph, Jones, Jeffrey, Johnson, Amy J., Andritsos, Leslie, Maddocks, Kami, Jaglowski, Samantha, Hessler, Joshua, Grever, Michael R., Ellie, Im, Zhou, Honghong, Zhu, Yali, Zhang, Da, Small, Karen, Bannerji, Rajat, Byrd, John C.
Publicado 2015

Impact of Targeted Therapy on Outcome of Chronic Lymphocytic Leukemia Patients with Relapsed Del(17p13.1) Karyotype at a Single Center

por Stephens, Deborah M., Ruppert, Amy S., Jones, Jeffrey, Woyach, Jennifer, Maddocks, Kami, Jaglowski, Samantha, Andritsos, Leslie A., Flynn, Joseph M., Grever, Michael R., Lozanski, Gerard, Johnson, Amy J., Muthusamy, Natarajan, Heerema, Nyla A., Byrd, John C.
Publicado 2014

Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma

por Epperla, Narendranath, Ahn, Kwang Woo, Ahmed, Sairah, Jagasia, Madan, DiGilio, Alyssa, Devine, Steven M., Jaglowski, Samantha, Kennedy, Vanessa, Rezvani, Andrew R., Smith, Sonali M., Sureda, Anna, Fenske, Timothy S., Kharfan-Dabaja, Mohamed A., Armand, Phillipe, Hamadani, Mehdi
Publicado 2017

Second Cancer Incidence in CLL Patients Receiving BTK Inhibitors

por Bond, David A, Huang, Ying, Fisher, James L, Ruppert, Amy S, Owen, Dwight H, Bertino, Erin M, Rogers, Kerry A, Bhat, Seema A, Grever, Michael R, Jaglowski, Samantha M, Maddocks, Kami J, Byrd, John C, Woyach, Jennifer A
Publicado 2020

Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare Ecosystem

por Koo, Jane, Auletta, Jeffrey J., Hartley, David M., Huber, John, Jaglowski, Samantha, Kapadia, Malika, Kusnier, Katilyn, Lehmann, Leslie, Maakaron, Joseph, Myers, Kasiani C., Pai, Ahna, Parker, Loretta, Phelan, Rachel, Sper, Christine, Rotz, Seth J., Dandoy, Christopher E.
Publicado 2022

Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional Experience

por Jiang, Justin, Sigmund, Audrey M., Zhao, Qiuhong, Elder, Patrick, Benson, Don M., Vasu, Sumithira, Jaglowski, Samantha, Mims, Alice, Choe, Hannah, Larkin, Karilyn, Brammer, Jonathan E., Wall, Sarah, Grieselhuber, Nicole, Saad, Ayman, Penza, Sam, Efebera, Yvonne A., Sharma, Nidhi
Publicado 2022

Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor

por Crees, Zachary D., Rettig, Michael P., Bashey, Asad, Devine, Steven M., Jaglowski, Samantha, Wan, Fei, Zhou, Amy, Harding, Melinda, Vainstein-Haras, Abi, Sorani, Ella, Gliko-Kabir, Irit, Grossman, Brenda J., Westervelt, Peter, DiPersio, John F., Uy, Geoffrey L.
Publicado 2023

Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents

por Faisal, Muhammad Salman, Hanel, Walter, Voorhees, Timothy, Li, Rui, Huang, Ying, Khan, Abdullah, Bond, David, Sawalha, Yazeed, Reneau, John, Alinari, Lapo, Baiocchi, Robert, Christian, Beth, Maddocks, Kami, Efebera, Yvonne, Penza, Sam, Saad, Ayman, Brammer, Jonathan, DeLima, Marcos, Jaglowski, Samantha, Epperla, Narendranath
Publicado 2023

Acute GVHD, BK virus hemorrhagic cystitis and age are risk factors for transplant-associated thrombotic microangiopathy in adults

por Vasu, Sumithira, Bostic, Matthew, Zhao, Qiuhong, Sharma, Nidhi, Puto, Marcin, Knight, Samantha, Scott, Denise, Guzman, Rosalyn, Kromer, Meghan, Tackett, Karen, Lind, Kristin, Knill, Kathryn, Watson, Emily, Wall, Sarah, Saad, Ayman, Choe, Hannah, Larkin, Karilyn, Brammer, Jonathan, Jaglowski, Samantha, Penza, Sam, Davies, Stella M., Cataland, Spero
Publicado 2022

Impact of Race and Geographic Area of Residence on Outcomes After Allogeneic Stem Cell Transplant

por Sigmund, Audrey M., Zhao, Qiuhong, Jiang, Justin, Elder, Patrick, Benson, Don M., Rosko, Ashley, Bumma, Naresh, Khan, Abdullah, Devarakonda, Srinivas, Vasu, Sumithira, Jaglowski, Samantha, Mims, Alice, Choe, Hannah, Larkin, Karilyn, Brammer, Jonathan, Wall, Sarah, Grieselhuber, Nicole, Saad, Ayman, Penza, Sam, Efebera, Yvonne A., Sharma, Nidhi
Publicado 2022

P1071: COMBINATION OF PD-1 INHIBITION WITH IMMUNOMODULATORY DRUG TREATMENT IN HODGKIN AND LARGE B-CELL LYMPHOMA: RESULTS FROM A PHASE I/II STUDY

por Bond, David, Yildiz, Vedat, Wei, Lai, Reneau, John, Sawalha, Yazeed, Christian, Beth, Brammer, Jonathan, Koff, Jean, Epperla, Narendranath, Dendorfer, Aubree, Yang, Lily, Robert, Baiocchi, Voorhees, Timothy, Sigmund, Audrey, Hanel, Walter, Shindiapina, Polina, Denlinger, Nathan, Penza, Sam, Jaglowski, Samantha, Bezerra, Evandro, Alinari, Lapo, Blum, Kristie, Maddocks, Kami
Publicado 2023

Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation

por Sharma, Nidhi, Zhao, Qiuhong, Ni, Bin, Elder, Patrick, Puto, Marcin, Benson, Don M., Rosko, Ashley, Chaudhry, Maria, Devarakonda, Srinivas, Bumma, Naresh, Khan, Abdullah, Vasu, Sumithira, Jaglowski, Samantha, William, Basem M., Mims, Alice, Choe, Hannah, Larkin, Karilyn, Brammer, Jonathan, Wall, Sarah, Grieselhuber, Nicole, Saad, Ayman, Penza, Sam, Efebera, Yvonne
Publicado 2021